Michel Vounatsos, Biogen CEO (via YouTube)

June 18, 2020 10:29 AM EDT

In a fresh blow, Biogen loses a big court fight with Mylan over its blockbuster Tecfidera patent

John Carroll

Editor & Founder

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Novartis won bidding war for kidney drug as Regulus' top three execs expect to make over $100M combined

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Biogen taps City Therapeutics in RNAi deal worth up to $1B

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation